Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV December 3, 2025 thumbnail

Introduction

story 1 thumbnail

Eylea HD Gains FDA Approval for New Indication and Dosing Schedule

story 2 thumbnail

Byooviz, Biosimilar to Lucentis, Approved in Europe as Pre-Filled Syringe

story 3 thumbnail

Phase 3 Results for Belite Bio's Stargardt Disease Drug Candidate


Previous EyewireTV Episodes